IONS Insider Transactions — Page 9
1,448 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 801–900; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| CROOKE STANLEY T | Chairman and CEO | 2015-01-09 | Sale | 1,000.0 | $73.57 |
| CROOKE STANLEY T | Chairman and CEO | 2015-01-09 | Sale | 10,000.0 | $73.57 |
| CROOKE STANLEY T | Chairman and CEO | 2015-01-07 | Sale | 1,000.0 | $68.05 |
| CROOKE STANLEY T | Chairman and CEO | 2015-01-07 | Sale | 10,000.0 | $68.05 |
| CROOKE STANLEY T | Chairman and CEO | 2015-01-06 | Sale | 1,000.0 | $66.04 |
| CROOKE STANLEY T | Chairman and CEO | 2015-01-06 | Sale | 10,000.0 | $66.04 |
| PARSHALL B LYNNE | COO & Secretary | 2015-01-02 | Sale | 11,200.0 | $62.12 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2015-01-02 | Sale | 283.0 | $62.12 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2015-01-02 | Sale | 1,217.0 | $62.12 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2015-01-02 | Sale | 76.0 | $62.75 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-12-01 | Sale | 500.0 | $50.37 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-12-01 | Sale | 500.0 | $51.05 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-12-01 | Sale | 500.0 | $52.21 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-11-03 | Sale | 1,500.0 | $46.17 |
| PARSHALL B LYNNE | COO & Secretary | 2014-10-30 | Sale | 8,561.0 | $45.12 |
| PARSHALL B LYNNE | COO & Secretary | 2014-10-30 | Sale | 2,510.0 | $45.12 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-23 | Sale | 1,600.0 | $42.22 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-23 | Sale | 10,000.0 | $42.22 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-23 | Sale | 3,000.0 | $42.22 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-03 | Sale | 1,000.0 | $39.49 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-03 | Sale | 13,000.0 | $39.49 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-01 | Sale | 800.0 | $37.91 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-01 | Sale | 1,200.0 | $37.91 |
| CROOKE STANLEY T | Chairman and CEO | 2014-10-01 | Sale | 20,000.0 | $37.91 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-10-01 | Sale | 800.0 | $37.9 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-10-01 | Sale | 467.0 | $38.2 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-10-01 | Sale | 233.0 | $38.2 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-09-02 | Sale | 700.0 | $40.6 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-09-02 | Sale | 800.0 | $40.3 |
| PARSHALL B LYNNE | COO | 2014-09-02 | Sale | 443.0 | $40.24 |
| PARSHALL B LYNNE | COO | 2014-09-02 | Sale | 10,628.0 | $40.24 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-08-27 | Sale | 2,000.0 | $40.55 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-08-27 | Sale | 1,000.0 | $40.53 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-08-27 | Sale | 2,000.0 | $40.5 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-08-26 | Sale | 10,000.0 | $38.14 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-08-26 | Sale | 15,000.0 | $38.14 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-08-26 | Sale | 2,344.0 | $38.14 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-08-13 | Sale | 1,600.0 | $35.45 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-08-13 | Sale | 15,500.0 | $35.45 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-08-12 | Sale | 800.0 | $35.0 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-08-11 | Sale | 700.0 | $35.0 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-08-01 | Sale | 1,000.0 | $30.53 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-08-01 | Sale | 15,000.0 | $30.53 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-07-31 | Sale | 79.0 | $31.5 |
| Geary Richard S | SVP, Development | 2014-07-02 | Sale | 164.0 | $35.95 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-07-01 | Sale | 1,500.0 | $35.33 |
| CROOKE STANLEY T | Chairman and CEO | 2014-07-01 | Sale | 1,800.0 | $35.55 |
| CROOKE STANLEY T | Chairman and CEO | 2014-07-01 | Sale | 200.0 | $35.55 |
| CROOKE STANLEY T | Chairman and CEO | 2014-07-01 | Sale | 15,500.0 | $35.58 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-06-23 | Sale | 5,000.0 | $36.54 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-06-23 | Sale | 6,200.0 | $36.97 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-19 | Sale | 67.0 | $35.27 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-19 | Sale | 100.0 | $35.28 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-19 | Sale | 200.0 | $35.29 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-19 | Sale | 300.0 | $35.45 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-19 | Sale | 33.0 | $35.27 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-06-19 | Sale | 11,000.0 | $35.1 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-16 | Sale | 100.0 | $35.27 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-16 | Sale | 100.0 | $35.25 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-16 | Sale | 400.0 | $35.02 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-06-16 | Sale | 200.0 | $35.25 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-06-10 | Sale | 1,000.0 | $33.46 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-06-10 | Sale | 10,000.0 | $33.46 |
| MUTO FREDERICK T | Director | 2014-06-02 | Sale | 10,000.0 | $28.59 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-04-02 | Sale | 1,800.0 | $43.65 |
| CROOKE STANLEY T | Chairman, President and CEO | 2014-04-02 | Sale | 7,000.0 | $43.65 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-04-01 | Sale | 500.0 | $44.02 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-04-01 | Sale | 500.0 | $44.3 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2014-04-01 | Sale | 500.0 | $44.88 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-03-03 | Sale | 800.0 | $50.7 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-03-03 | Sale | 330.0 | $49.2 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-03-03 | Sale | 370.0 | $49.2 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2014-02-03 | Sale | 1,500.0 | $50.45 |
| WENDER JOSEPH H | Director | 2014-02-03 | Sale | 4,700.0 | $48.78 |
| PARSHALL B LYNNE | COO | 2014-01-30 | Sale | 15,875.0 | $50.36 |
| PARSHALL B LYNNE | COO | 2014-01-30 | Sale | 23,635.0 | $50.36 |
| PARSHALL B LYNNE | COO | 2014-01-29 | Sale | 5,000.0 | $48.81 |
| PARSHALL B LYNNE | COO | 2014-01-29 | Sale | 5,000.0 | $48.81 |
| PARSHALL B LYNNE | COO | 2014-01-29 | Sale | 5,000.0 | $48.81 |
| PARSHALL B LYNNE | COO | 2014-01-29 | Sale | 31,028.0 | $48.81 |
| PARSHALL B LYNNE | COO | 2014-01-29 | Sale | 3,972.0 | $48.81 |
| KLEIN JOSEPH III | Director | 2014-01-24 | Sale | 2,813.0 | $48.61 |
| KLEIN JOSEPH III | Director | 2014-01-24 | Sale | 7,500.0 | $48.68 |
| Geary Richard S | SVP, Development | 2014-01-22 | Sale | 13,900.0 | $50.05 |
| Geary Richard S | SVP, Development | 2014-01-22 | Sale | 8,300.0 | $50.05 |
| WENDER JOSEPH H | Director | 2014-01-22 | Sale | 10,000.0 | $50.98 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-01-16 | Sale | 265.0 | $47.08 |
| BENNETT C FRANK | SVP, Antisense Research | 2014-01-16 | Sale | 539.0 | $47.08 |
| Geary Richard S | SVP, Development | 2014-01-16 | Sale | 533.0 | $47.08 |
| Geary Richard S | SVP, Development | 2014-01-16 | Sale | 296.0 | $47.08 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2014-01-16 | Sale | 120.0 | $47.08 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2014-01-16 | Sale | 207.0 | $47.08 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2014-01-16 | Sale | 250.0 | $47.08 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-01-16 | Sale | 202.0 | $47.08 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-01-16 | Sale | 80.0 | $47.08 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2014-01-16 | Sale | 539.0 | $47.08 |
| PARSHALL B LYNNE | COO & Secretary | 2014-01-16 | Sale | 988.0 | $47.08 |
| PARSHALL B LYNNE | COO & Secretary | 2014-01-16 | Sale | 653.0 | $47.08 |
| CROOKE STANLEY T | Chairman and CEO | 2014-01-16 | Sale | 121.0 | $47.08 |
| CROOKE STANLEY T | Chairman and CEO | 2014-01-16 | Sale | 160.0 | $47.08 |